Tempus AI Return on Tangible Equity 2023-2025 | TEM

Current and historical return on tangible equity values for Tempus AI (TEM) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Tempus AI Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $-0.72B $-0.40B 636.64%
2024-12-31 $-0.75B $-0.03B 184.08%
2024-09-30 $-0.78B $-0.03B 102.05%
2024-06-30 $-0.77B $0.01B 101.75%
2024-03-31 $-0.28B $-1.57B 36.14%
2023-12-31 $-0.25B $-1.48B 67.16%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $10.012B $0.693B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.234B 52.81
Hims & Hers Health (HIMS) United States $12.982B 134.88
IRhythm Technologies (IRTC) United States $4.465B 0.00
Inspire Medical Systems (INSP) United States $4.309B 67.32
Privia Health (PRVA) United States $2.902B 198.33
Enovis (ENOV) United States $1.848B 10.30
Clover Health Investments (CLOV) United States $1.791B 0.00
Schrodinger (SDGR) United States $1.498B 0.00
Phreesia (PHR) United States $1.456B 0.00
Omnicell (OMCL) United States $1.281B 22.59
Azenta (AZTA) United States $1.258B 58.47
10x Genomics (TXG) United States $1.024B 0.00
Fulgent Genetics (FLGT) United States $0.618B 0.00
Butterfly Network (BFLY) United States $0.534B 0.00
Talkspace (TALK) United States $0.486B 145.25
Veradigm (MDRX) United States $0.476B 0.00
Claritev (CTEV) United States $0.473B 0.00
Standard BioTools (LAB) United States $0.395B 0.00
TruBridge (TBRG) United States $0.363B 805.00
Nyxoah SA (NYXH) Belgium $0.274B 0.00
Health Catalyst (HCAT) United States $0.260B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.195B 0.00
EUDA Health Holdings (EUDA) Singapore $0.141B 0.00
Pulmonx (LUNG) United States $0.126B 0.00
American Well (AMWL) United States $0.116B 0.00
MDxHealth SA (MDXH) Belgium $0.099B 0.00
CareCloud (CCLD) United States $0.086B 3.27
111 (YI) China $0.067B 0.00
Outset Medical (OM) United States $0.067B 0.00
P3 Health Partners (PIII) United States $0.056B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
Retrieve Medical Holdings (RMHI) United States $0.051B 0.00
Zepp Health (ZEPP) Netherlands $0.038B 0.00
Zhongchao (ZCMD) China $0.033B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Precipio (PRPO) United States $0.015B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Streamline Health Solutions (STRM) United States $0.009B 0.00
Movano (MOVE) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00